Prognostic stratification of endometrial cancers with high microsatellite instability or no specific molecular profile

ObjectiveTo identify high-risk disease in clinicopathologic low-risk endometrial cancer (EC) with high microsatellite instability (MSI-H) or no specific molecular profile (NSMP) and therapeutic insensitivity in clinicopathologic high-risk MSI-H/NSMP EC.MethodsWe searched The Cancer Genome Atlas for...

Full description

Bibliographic Details
Main Authors:	Jesus Gonzalez-Bosquet, S. John Weroha, Jamie N. Bakkum-Gamez, Amy L. Weaver, Michaela E. McGree, Sean C. Dowdy, Abimbola O. Famuyide, Benjamin R. Kipp, Kevin C. Halling, Siddhartha Yadav, Fergus J. Couch, Karl C. Podratz
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Oncology
Subjects:	CCNA2 ECPPF E2F1 endometrial cancer FBXW7 MSI
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1105504/full

Similar Items

ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer.
by: Jesus Gonzalez-Bosquet, et al.
Published: (2022-01-01)

ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer
by: Jesus Gonzalez-Bosquet, et al.
Published: (2022-01-01)

Estrogen-regulated PTTG1 promotes breast cancer progression by regulating cyclin kinase expression
by: Chunhui Meng, et al.
Published: (2020-04-01)

Long Non-coding RNA LINC-PINT Suppresses Cell Proliferation and Migration of Melanoma via Recruiting EZH2
by: Yangfan Xu, et al.
Published: (2019-12-01)

Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options.
by: Jesus Gonzalez Bosquet, et al.
Published: (2021-01-01)

Integrated Protein–Protein Interaction and Weighted Gene Co-expression Network Analysis Uncover Three Key Genes in Hepatoblastoma
by: Linlin Tian, et al.
Published: (2021-02-01)

Unraveling a novel therapeutic facet of Etravirine to confront Hepatocellular Carcinoma via disruption of cell cycle
by: Gouri Nair, et al.
Published: (2025-02-01)

FBXW7 gene polymorphism is associated with type 2 diabetes in the Uygur population in Xinjiang, China
by: Shi-Qi Yan, et al.
Published: (2021-08-01)

Construction of a prognostic model based on disulfidptosis-related genes and identification of CCNA2 as a novel biomarker for hepatocellular carcinoma
by: Tao Wang, et al.
Published: (2024-12-01)

Silencing of LncRNA AFAP1-AS1 Inhibits Cell Proliferation in Oral Squamous Cancer by Suppressing CCNA2
by: Li T, et al.
Published: (2021-10-01)

Screening of potential hub genes involved in Kidney Wilms tumor via bioinformatics analysis and experimental validation
by: Qiang Zeng, et al.
Published: (2024-06-01)

Decreased expression of LATS1 is correlated with the progression and prognosis of glioma
by: Ji Tianhai, et al.
Published: (2012-08-01)

Sulfatase modifying factor 2 as a predictive biomarker for urothelial carcinoma
by: Wei-Ting Kuo, et al.
Published: (2025-02-01)

CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer
by: Gan Y, et al.
Published: (2018-10-01)

Microsatellite instability: a review of what the oncologist should know
by: Kai Li, et al.
Published: (2020-01-01)

Concordance in detection of microsatellite instability by PCR and NGS in routinely processed tumor specimens of several cancer types
by: Stephan Bartels, et al.
Published: (2023-08-01)

The Predictive Competing Endogenous RNA Regulatory Networks and Potential Prognostic and Immunological Roles of Cyclin A2 in Pan-Cancer Analysis
by: Shenyong Chen, et al.
Published: (2022-04-01)

Cyclin A1 (CCNA1) inhibits osteoporosis by suppressing transforming growth factor-beta (TGF-beta) pathway in osteoblasts
by: Xiao Du, et al.
Published: (2024-03-01)

Activation of the integrated stress response is a vulnerability for multidrug‐resistant FBXW7‐deficient cells
by: Laura Sanchez‐Burgos, et al.
Published: (2022-07-01)

E3 Ligase FBXW2 Is a New Therapeutic Target in Obesity and Atherosclerosis
by: Cheng Wang, et al.
Published: (2020-10-01)

Roles of Two F-Box Proteins: FBXL14 in the Periosteum and FBXW2 at Elastic Fibers
by: Mari Akiyama
Published: (2023-01-01)

Role of FBXW2 in explant cultures of bovine periosteum-derived cells
by: Mari Akiyama
Published: (2021-11-01)

β-Carboline dimers inhibit the tumor proliferation by the cell cycle arrest of sarcoma through intercalating to Cyclin-A2
by: Huiya Ma, et al.
Published: (2022-10-01)

FBXW7 promotes autophagy and inhibits proliferation of oral squamous cell carcinoma
by: Bo Qiu, et al.
Published: (2023-05-01)

Examination of the expression levels of MACC1, Filamin A and FBXW7 genes in colorectal cancer patients
by: Funda Yeşilkaya, et al.
Published: (2020-02-01)

Alteration in Expression of miR-32 and FBXW7 Tumor Suppressor in Plasma Samples of Patients with T-cell Acute Lymphoblastic Leukemia
by: Mansouri S, et al.
Published: (2020-02-01)

MiR-29c-3p Suppresses the Migration, Invasion and Cell Cycle in Esophageal Carcinoma via CCNA2/p53 Axis
by: Haiyong Wang, et al.
Published: (2020-02-01)

CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma
by: Hongyi Li, et al.
Published: (2021-10-01)

FBXW7 promotes ferroptosis in head and neck squamous cell carcinoma cells through inhibiting c-Myc/SOX2/SLC7A11
by: CHEN Yiren, ZHAO Zhenyuan, ZHENG Yangyu, ZHANG Wei, SONG Xiaomeng
Published: (2024-06-01)

Proteomic profiling of FBXW7‐mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target
by: Mary Ellen Urick, et al.
Published: (2020-06-01)

FBXW2 suppresses proliferation and invasion of lung cancer cells by targeting SKP2 and β-catenin
by: Fei Yang, et al.
Published: (2019-07-01)

Microsatellite instability-high gastric cancer patients may benefit from adjuvant radiotherapy
by: Suzana Janković, et al.
Published: (2023-01-01)

Comprehensive analysis pinpoints CCNA2 as a prognostic and immunological biomarker in non-small cell lung cancer
by: Liming Zhang, et al.
Published: (2025-01-01)

Haploid genetic screens identify genetic vulnerabilities to microtubule‐targeting agents
by: Nora M. Gerhards, et al.
Published: (2018-06-01)

FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy
by: Yi Xiao, et al.
Published: (2018-06-01)

Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis
by: Wei Shang, et al.
Published: (2021-07-01)

Clinical, pathological, and adjuvant chemotherapy use differences among microsatellite unstable and microsatellite stable colon cancers
by: Baqir Hasan Jafry, et al.
Published: (2024-06-01)

MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2
by: Qiang Ma
Published: (2019-02-01)

Protection by collagen peptides from walleye pollock skin on bone formation via inhibition of oxidative stress
by: Feng Liu, et al.
Published: (2020-07-01)

Application of AP-MALDI Imaging Mass Microscope for the Rapid Mapping of Imipramine, Chloroquine, and Their Metabolites in the Kidney and Brain of Wild-Type Mice
by: Ariful Islam, et al.
Published: (2022-10-01)